<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>John Auer first described needle or rod-shaped intracytoplasmic inclusion bodies in <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells in 1906 </plain></SENT>
<SENT sid="1" pm="."><plain>Auer rods can be seen in myeloid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> ranging from <z:hpo ids='HP_0004808'>acute myeloid leukemias</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) to <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>, but not in <z:mpath ids='MPATH_458'>normal</z:mpath> or non-neoplastic reactive states </plain></SENT>
<SENT sid="2" pm="."><plain>This article briefly describes John Auer's experience and discusses debates on Auer rods, and criticizes their place in the definition of <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts-2 (<z:e sem="disease" ids="C1318551" disease_type="Neoplastic Process" abbrv="">RAEB-2</z:e>) in the WHO classification of the <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
</text></document>